Gene Therapy Market Forecast Highlighting Key Trends And Expansion Potential

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Market Size Of The Gene Therapy Market Expected To Change From 2026 To 2030?

The gene therapy market has witnessed substantial expansion in recent years. Its value is projected to climb from $16.36 billion in 2025 to $21.46 billion in 2026, indicating a compound annual growth rate (CAGR) of 31.2%. The historical increase can be attributed to the rising prevalence of genetic disorders, advancements in viral vector technology, greater r&d investments in gene therapy, encouraging government policies, and increased awareness of rare diseases.

The gene therapy market is poised for substantial growth in the coming years. It is projected to reach $35.61 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 13.5%.

The foreseen expansion during this period can be attributed to factors such as the broadening scope of personalized medicine, the emergence of CRISPR and other gene editing therapies, a rise in both private and public funding, the integration of artificial intelligence into gene therapy research, and an increase in collaborative international clinical trials.

Significant trends anticipated for the forecast period include the ongoing development of personalized gene therapies, wider adoption of CRISPR and gene editing technologies, an expansion of regulatory and ethical frameworks, innovations in advanced viral and non-viral vectors, and continued collaborative research alongside clinical trials.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3395&type=smp

What Key Drivers Are Fueling The Growth Of The Gene Therapy Market?

Increased financial commitment in the healthcare sector is anticipated to drive the expansion of the gene therapy market in the future. This type of investment involves dedicating capital to entities that offer medical services, produce medical devices or pharmaceuticals, offer health insurance, or contribute to the broader healthcare domain. Such investments are crucial for the gene therapy industry, given that numerous pharmaceutical firms are channeling funds to bolster their patent holdings and forge profitable partnerships. Furthermore, strategic funding facilitates the creation of innovative and sophisticated gene therapy solutions. For example, in April 2025, the American Medical Association, a US-based Professional organizations, reported that U.S. health spending in 2023 rose by 7.5% to $4.9 trillion, equating to $14,570 per capita, which exceeded the 4.6% increase recorded in 2022. Consequently, the increased financial input into the healthcare industry is fueling the expansion of the gene therapy market.

How Is The Gene Therapy Market Segmented Across Different Segment Categories?

The gene therapy market covered in this report is segmented –

1) By Gene Therapy Type: Germline Therapy, Somatic Cell Therapy

2) By Vector: Viral Vector, Non-Viral Vector

3) By Application: Oncology, Orphan Disease, Knee Osteoarthritis, Neurological Disorders

4) By End Users: Biopharmaceutical Companies, Research Institutes, Other End Users

Subsegments:

1) By Germline Therapy: Inherited Disease Treatment, Genetic Modification Of Embryos, Gene Editing Techniques, Ethical And Regulatory Considerations

2) By Somatic Cell Therapy: Cancer Gene Therapy, Monogenic Disorder Treatment, Gene Replacement Therapy, RNA-Based Therapies, Gene Editing Techniques

What Market Trends Are Affecting The Gene Therapy Market?

Major companies operating in the gene therapy market are primarily focused on developing advanced products, including adeno-associated virus (AAV) vectors, to enhance the precision and effectiveness of gene delivery in treating various genetic disorders. An adeno-associated virus (AAV) vector is a widely utilized tool in gene therapy for delivering genetic material into cells. For example, in April 2024, Pfizer Inc., a US-based global biopharmaceutical company, received approval from the Food and Drug Administration (FDA), a US-based federal agency for protecting the public health, for BEQVEZ (fidanacogene elaparvovec-dzkt). BEQVEZ (fidanacogene elaparvovec-dzkt) is a gene therapy intended for treating adults with moderate to severe hemophilia B, a genetic bleeding disorder marked by a deficiency in clotting factor IX (FIX) that can result in excessive bleeding. This therapy employs an adeno-associated virus (AAV) vector to deliver a functional copy of the FIX gene directly into liver cells, thereby enabling the natural production of this vital clotting factor.

Which Organizations Play A Role In The Gene Therapy Market Landscape?

Major companies operating in the gene therapy market are UniQure NV, REGENXBIO Inc., Bristol-Myers Squibb, BioMarin Pharmaceuticals Inc., Jazz Pharmaceuticals Inc., Biocon, EdiGene Inc, Takeda Pharmaceutical, Daiichi Sankyo Company, Mitsubishi Tanabe Pharma, Merck, Lonza, Pfizer, Cellular Biomedicine Group, GenScript, Albumedix Ltd, Catalent, Freeline Therapeutics, DiNAQOR AG, Vivet Therapeutics, Allergan, Amgen, Biocad, Celgene Corporation, Johnson & Johnson, Eli Lilly and Company, AstraZeneca, Bayer AG, Juno Therapeutics, Allogene Therapeutics, Bluebird Bio, Regen BioPharma, Bellicum, BrainStorm Cell Therapeutics, Pluristem, Sanofi

Get The Full Gene Therapy Market Report:

https://www.thebusinessresearchcompany.com/report/genes-therapy-global-market-report

Which Region Dominates The Gene Therapy Market By Market Share?

North America was the largest region in the gene therapy market in 2025. The regions covered in the gene therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Gene Therapy Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/genes-therapy-global-market-report

Browse Through More Reports Similar to the Global Gene Therapy Market 2026, By The Business Research Company

Genes Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/genes-therapy-global-market-report

Nucleic Acid Based Gene Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/nucleic-acid-based-gene-therapy-global-market-report

Gene Editing Market Report 2026

https://www.thebusinessresearchcompany.com/report/gene-editing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795